» Articles » PMID: 11910347

Dietary Sphingomyelin Suppresses Intestinal Cholesterol Absorption by Decreasing Thermodynamic Activity of Cholesterol Monomers

Overview
Specialty Gastroenterology
Date 2002 Mar 23
PMID 11910347
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: In humans, cholesterol absorbed from the intestine contributes appreciably to serum cholesterol levels. We hypothesized that cholesterol thermodynamic activity (A(t)) would predict bioavailability of cholesterol monomers in intestinal content, and that natural dietary phospholipids exhibiting high affinity for cholesterol would reduce its absorption.

Methods: Cholesterol A(t) was determined by measuring partitioning of monomeric cholesterol from aqueous solutions of taurocholate, cholesterol, and either milk sphingomyelin (MSM), dipalmitoyl phosphatidylcholine (DPPC), or egg yolk phosphatidylcholine (EYPC) into wafers of polymerized silicone. Cholesterol absorption from the same mixtures was tested with monolayers of Caco-2 cells. For in vivo absorption studies (employing male C57L/J mice), we used the fecal dual isotope method during dietary enrichment with MSM, DPPC, or EYPC at varying dose levels.

Results: Cholesterol A(t) values were reduced significantly in MSM- and DPPC-containing systems compared with EYPC and correlated positively with reduced uptake and esterification of cholesterol by Caco-2 cells. Mice fed chow absorbed 31.4% +/- 6.9% (mean +/- SEM) cholesterol, whereas enrichment with MSM or DPPC led to dose-dependent decreases in cholesterol absorption; even at 0.1% MSM, cholesterol absorption was reduced by 20.4% +/- 15.4% (P < 0.05, n = 6).

Conclusions: Different phospholipids have distinct effects on micellar cholesterol A(t), which predicts cholesterol uptake by enterocytes in vitro as well as in vivo. Natural phospholipids with high affinity for cholesterol, as evidenced particularly by sphingomyelin, decrease A(t) and curtail intestinal cholesterol absorption.

Citing Articles

Emerging Roles for Sphingolipids in Cardiometabolic Disease: A Rational Therapeutic Target?.

Foran D, Antoniades C, Akoumianakis I Nutrients. 2024; 16(19).

PMID: 39408263 PMC: 11478599. DOI: 10.3390/nu16193296.


Nutritional roles and therapeutic potentials of dietary sphingomyelin in brain diseases.

Alashmali S J Clin Biochem Nutr. 2024; 74(3):185-191.

PMID: 38799143 PMC: 11111474. DOI: 10.3164/jcbn.23-97.


The impacts of dietary sphingomyelin supplementation on metabolic parameters of healthy adults: a systematic review and meta-analysis of randomized controlled trials.

Li C, Wu L, Zhu C, Du H, Chen G, Yang F Front Nutr. 2024; 11:1363077.

PMID: 38463938 PMC: 10922005. DOI: 10.3389/fnut.2024.1363077.


Comparison of the impact of saturated fat from full-fat yogurt or low-fat yogurt and butter on cardiometabolic factors: a randomized cross-over trial.

Rajabpour Ranjbar Y, Nasrollahzadeh J Eur J Nutr. 2024; 63(4):1213-1224.

PMID: 38367032 DOI: 10.1007/s00394-024-03352-8.


Whole-Milk Dairy Foods: Biological Mechanisms Underlying Beneficial Effects on Risk Markers for Cardiometabolic Health.

Torres-Gonzalez M, Rice Bradley B Adv Nutr. 2023; 14(6):1523-1537.

PMID: 37684008 PMC: 10721525. DOI: 10.1016/j.advnut.2023.09.001.